P.339 Pharmacogenetic testing in bipolar disorder: is it useful?

Gerard Anmella; Giovanna Fico; A. Torres; M. Sagué; María Teresa Pons-Cabrera; Santiago Madero; Isabella Pacchiarotti; Norma Verdolini; Marina Garriga; Eduard Vieta; Andréa Murru

doi:10.1016/j.euroneuro.2020.09.258

Related publications

Article2010

Functional impairment in bipolar II disorder: Is it as disabling as bipolar I?

Adriane Ribeiro Rosa, Caterina del Mar Bonnín, Gustavo Vázquez, María Reinares, Brisa Solé, Rafael Tabarés‐Seisdedos, Vicent Balanzá‐Martínez, Ana González‐Pinto, José Sánchez‐Moreno, Eduard Vieta

Article2013

“Is bipolar disorder an endocrine condition?” Glucose abnormalities in bipolar disorder

Clemente García‐Rizo, Brian Kirkpatrick, Emilio Fernández-Egea, Cristina Oliveira, Ana Meseguer, Iría Grande, Juan Undurraga, Eduard Vieta, Miquel Bernardo

Article2003

Obesity – is it a genetic disorder?

Ruth J. F. Loos, Claude Bouchard

Journal of Internal Medicine

Article2011

Hypersomnia in inter-episode bipolar disorder: Does it have prognostic significance?

Katherine A. Kaplan, June Gruber, Polina Eidelman, Lisa S. Talbot, Allison G Harvey

Article2009

The Child Behavior Checklist (CBCL) and the CBCL-Bipolar Phenotype Are Not Useful in Diagnosing Pediatric Bipolar Disorder

Rasim Somer Diler, Boris Birmaher, David Axelson, Ben Goldstein, MaryKay Gill, Michael Strober, David J. Kolko, Tina R. Goldstein, Jeffrey Hunt, Mei Yang, Neal D. Ryan, Satish Iyengar, Ronald E Dahl, Lorah D. Dorn, Martin B. Keller